CannTrust Meets Consumer Needs with Three New CBD Product Formulations; Positions Itself to Triple Annual Capacity

By April 11, 2019 No Comments

Capture-17CannTrust Holdings Inc. (NYSE: CTST) just announced that the company has launched three new cannabidiol (CBD) product variations in order to meet consumer demands.

The three new CBD formulation products are: A high dose CBD capsule (25mg per capsule), high dose CDB drops (50mg per mL), and a low dose CBD and tetrahydrocannabinol (THC) capsule (2.5mg of CBD and 2.5mg of THC for a 1:1 ratio).

The new high dose capsules that each contain 25mg of CBD is now the highest dose CBD capsule that is currently available for purchase in Canada. All the newly announced CannTrust products are available for purchase directly from the company’s website and the company’s Customer Care Center (that can be reached via 1-855-RX4-CANN).

The company’s product portfolio that contains different combination variations of CBD, THC, and both CBD & THC capsules and oils have increased to a current total of nine products. All nine of the company’s award-winning products are available to its patient list of 69,000 medical cannabis patients.

{{cta(‘8bda15e4-5341-4195-a3c9-920630e5666d’)}}

Health Canada, an oversight organization that monitors and regulates all aspects of cannabis products in Canada, reported a 29% increase in the cannabis oil products category from January to September of 2018.

CannTrust believes that it will successfully triple its annual production capacity after it made investments that enhanced its currently owned extraction equipment. The company is already considered to be a global leader in medicinal cannabis oil sales and capsule sales. It was reported by the company that it had sold 3,707 liters, or just less than 980 gallons, of cannabis oil in Q4 of 2018. The Q4 medical cannabis oil sales that CannTrust performed in Q4 of 2018 came to be 27% of the Canadian market share.

Chief Executive Officer of CannTrust, Peter Aceto, stated: “As a company that has prioritized the medical market since our inception, creating products and formulations to meet the needs of patients and healthcare practitioners in Canada and globally has always been, and will always remain, our primary focus.”

Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Source

Leave a Reply